Which has preferable earnings and valuation, ITGR or ATRC?

Integer has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 1.72 $102.81M $4.01 23.40 AtriCure $534.53M 2.59 -$11.45M -$0.10 N/A

Is ITGR or ATRC more profitable?

Integer has a net margin of 7.64% compared to AtriCure's net margin of -0.83%. Integer's return on equity of 12.83% beat AtriCure's return on equity. Company Net Margins Return on Equity Return on Assets Integer 7.64% 12.83% 6.51% AtriCure -0.83% 0.29% 0.22%

Does the media refer more to ITGR or ATRC?

In the previous week, Integer had 1 more articles in the media than AtriCure. MarketBeat recorded 5 mentions for Integer and 4 mentions for AtriCure. Integer's average media sentiment score of 0.51 beat AtriCure's score of 0.37 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AtriCure 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor ATRC or SMA?

In the previous week, AtriCure and AtriCure both had 4 articles in the media. Smartstop Self Storage REIT's average media sentiment score of 0.58 beat AtriCure's score of 0.37 indicating that Smartstop Self Storage REIT is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Smartstop Self Storage REIT 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ATRC or IART?

In the previous week, Integra LifeSciences had 2 more articles in the media than AtriCure. MarketBeat recorded 6 mentions for Integra LifeSciences and 4 mentions for AtriCure. Integra LifeSciences' average media sentiment score of 0.53 beat AtriCure's score of 0.37 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Integra LifeSciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, ATRC or ATEC?

AtriCure has higher earnings, but lower revenue than Alphatec. AtriCure is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 2.59 -$11.45M -$0.10 N/A Alphatec $764.16M 1.66 -$143.36M -$0.82 N/A

Is ATRC or ATEC more profitable?

AtriCure has a net margin of -0.83% compared to Alphatec's net margin of -15.93%. AtriCure's return on equity of 0.29% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets AtriCure -0.83% 0.29% 0.22% Alphatec -15.93% -1,183.84% -15.83%

Does the media prefer ATRC or ATEC?

In the previous week, Alphatec had 3 more articles in the media than AtriCure. MarketBeat recorded 7 mentions for Alphatec and 4 mentions for AtriCure. Alphatec's average media sentiment score of 0.42 beat AtriCure's score of 0.37 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alphatec 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, ATRC or ANGO?

AtriCure has higher revenue and earnings than AngioDynamics. AtriCure is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 2.59 -$11.45M -$0.10 N/A AngioDynamics $292.50M 1.74 -$33.99M -$0.75 N/A

Is ATRC or ANGO more profitable?

AtriCure has a net margin of -0.83% compared to AngioDynamics' net margin of -10.01%. AtriCure's return on equity of 0.29% beat AngioDynamics' return on equity. Company Net Margins Return on Equity Return on Assets AtriCure -0.83% 0.29% 0.22% AngioDynamics -10.01% -4.66% -3.08%

AtriCure (ATRC) Competitors

$27.30 +0.38 (+1.41%)

Closing price 06/9/2026 04:00 PM Eastern

Extended Trading

$27.30 0.00 (0.00%)

As of 06/9/2026 05:29 PM Eastern

Compare

ATRC vs. ITGR, SMA, IART, ATEC, and ANGO

Should you buy AtriCure stock or one of its competitors? MarketBeat compares AtriCure with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AtriCure include Integer (ITGR), Smartstop Self Storage REIT (SMA), Integra LifeSciences (IART), Alphatec (ATEC), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

How does AtriCure compare to Integer?

Integer (NYSE:ITGR) and AtriCure (NASDAQ:ATRC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, Integer had 1 more articles in the media than AtriCure. MarketBeat recorded 5 mentions for Integer and 4 mentions for AtriCure. Integer's average media sentiment score of 0.51 beat AtriCure's score of 0.37 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	1.72	$102.81M	$4.01	23.40
AtriCure	$534.53M	2.59	-$11.45M	-$0.10	N/A

Integer currently has a consensus price target of $98.71, suggesting a potential upside of 5.18%. AtriCure has a consensus price target of $48.71, suggesting a potential upside of 78.44%. Given AtriCure's stronger consensus rating and higher probable upside, analysts clearly believe AtriCure is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

Integer has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market. Comparatively, AtriCure has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

99.3% of Integer shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 4.0% of AtriCure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Integer has a net margin of 7.64% compared to AtriCure's net margin of -0.83%. Integer's return on equity of 12.83% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
AtriCure	-0.83%	0.29%	0.22%

Summary

Integer beats AtriCure on 10 of the 17 factors compared between the two stocks.

How does AtriCure compare to Smartstop Self Storage REIT?

AtriCure (NASDAQ:ATRC) and Smartstop Self Storage REIT (NYSE:SMA) are both small-cap health care equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

99.1% of AtriCure shares are owned by institutional investors. 4.0% of AtriCure shares are owned by company insiders. Comparatively, 5.5% of Smartstop Self Storage REIT shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Smartstop Self Storage REIT has lower revenue, but higher earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	2.59	-$11.45M	-$0.10	N/A
Smartstop Self Storage REIT	$281.14M	6.45	-$1.55M	$0.15	218.38

In the previous week, AtriCure and AtriCure both had 4 articles in the media. Smartstop Self Storage REIT's average media sentiment score of 0.58 beat AtriCure's score of 0.37 indicating that Smartstop Self Storage REIT is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Smartstop Self Storage REIT	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, Smartstop Self Storage REIT has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

Smartstop Self Storage REIT has a net margin of 4.38% compared to AtriCure's net margin of -0.83%. Smartstop Self Storage REIT's return on equity of 1.00% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
Smartstop Self Storage REIT	4.38%	1.00%	0.54%

AtriCure currently has a consensus target price of $48.71, suggesting a potential upside of 78.44%. Smartstop Self Storage REIT has a consensus target price of $37.17, suggesting a potential upside of 13.46%. Given AtriCure's higher probable upside, research analysts plainly believe AtriCure is more favorable than Smartstop Self Storage REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.73

Summary

Smartstop Self Storage REIT beats AtriCure on 11 of the 16 factors compared between the two stocks.

How does AtriCure compare to Integra LifeSciences?

AtriCure (NASDAQ:ATRC) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

AtriCure has higher earnings, but lower revenue than Integra LifeSciences. AtriCure is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	2.59	-$11.45M	-$0.10	N/A
Integra LifeSciences	$1.64B	0.85	-$516.47M	-$6.46	N/A

AtriCure has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market.

In the previous week, Integra LifeSciences had 2 more articles in the media than AtriCure. MarketBeat recorded 6 mentions for Integra LifeSciences and 4 mentions for AtriCure. Integra LifeSciences' average media sentiment score of 0.53 beat AtriCure's score of 0.37 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integra LifeSciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 4.0% of AtriCure shares are owned by insiders. Comparatively, 3.8% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

AtriCure presently has a consensus price target of $48.71, suggesting a potential upside of 78.44%. Integra LifeSciences has a consensus price target of $14.00, suggesting a potential downside of 21.79%. Given AtriCure's stronger consensus rating and higher probable upside, analysts plainly believe AtriCure is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

AtriCure has a net margin of -0.83% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
Integra LifeSciences	-30.15%	17.42%	5.00%

Summary

AtriCure beats Integra LifeSciences on 11 of the 17 factors compared between the two stocks.

How does AtriCure compare to Alphatec?

AtriCure (NASDAQ:ATRC) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

99.1% of AtriCure shares are held by institutional investors. Comparatively, 66.4% of Alphatec shares are held by institutional investors. 4.0% of AtriCure shares are held by insiders. Comparatively, 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Alphatec had 3 more articles in the media than AtriCure. MarketBeat recorded 7 mentions for Alphatec and 4 mentions for AtriCure. Alphatec's average media sentiment score of 0.42 beat AtriCure's score of 0.37 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alphatec	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

AtriCure has higher earnings, but lower revenue than Alphatec. AtriCure is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	2.59	-$11.45M	-$0.10	N/A
Alphatec	$764.16M	1.66	-$143.36M	-$0.82	N/A

AtriCure has a net margin of -0.83% compared to Alphatec's net margin of -15.93%. AtriCure's return on equity of 0.29% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
Alphatec	-15.93%	-1,183.84%	-15.83%

AtriCure has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Alphatec has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

AtriCure presently has a consensus price target of $48.71, suggesting a potential upside of 78.44%. Alphatec has a consensus price target of $18.58, suggesting a potential upside of 124.98%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

AtriCure beats Alphatec on 9 of the 17 factors compared between the two stocks.

How does AtriCure compare to AngioDynamics?

AtriCure (NASDAQ:ATRC) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

In the previous week, AtriCure had 3 more articles in the media than AngioDynamics. MarketBeat recorded 4 mentions for AtriCure and 1 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.87 beat AtriCure's score of 0.37 indicating that AngioDynamics is being referred to more favorably in the news media.

Company	Overall Sentiment
AtriCure	Neutral
AngioDynamics	Very Positive

AtriCure has higher revenue and earnings than AngioDynamics. AtriCure is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	2.59	-$11.45M	-$0.10	N/A
AngioDynamics	$292.50M	1.74	-$33.99M	-$0.75	N/A

AtriCure has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market.

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 4.0% of AtriCure shares are owned by company insiders. Comparatively, 6.0% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

AtriCure has a net margin of -0.83% compared to AngioDynamics' net margin of -10.01%. AtriCure's return on equity of 0.29% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
AngioDynamics	-10.01%	-4.66%	-3.08%

AtriCure presently has a consensus price target of $48.71, indicating a potential upside of 78.44%. AngioDynamics has a consensus price target of $18.67, indicating a potential upside of 51.27%. Given AtriCure's higher possible upside, equities analysts plainly believe AtriCure is more favorable than AngioDynamics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

AtriCure beats AngioDynamics on 12 of the 16 factors compared between the two stocks.

Get AtriCure News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATRC vs. The Competition

Export

Metric	AtriCure	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.36B	$8.43B	$6.65B	$12.06B
Dividend Yield	N/A	2.51%	2.67%	5.55%
P/E Ratio	-273.00	16.37	24.73	23.76
Price / Sales	2.59	6.89	507.94	105.22
Price / Cash	85.99	17.15	42.36	56.09
Price / Book	2.76	3.58	10.36	6.72
Net Income	-$11.45M	$225.32M	$3.56B	$337.35M
7 Day Performance	4.20%	1.27%	-0.96%	-1.21%
1 Month Performance	3.88%	2.78%	1.26%	1.41%
1 Year Performance	-18.24%	-3.04%	20.46%	23.64%

AtriCure Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
ATRC AtriCure	3.9942 of 5 stars	$27.30 +1.4%	$48.71 +78.4%	-20.1%	$1.36B	$534.53M	N/A	1,300
ITGR Integer	1.9456 of 5 stars	$89.49 +0.1%	$98.71 +10.3%	-23.1%	$3.03B	$1.86B	22.42	11,000
SMA Smartstop Self Storage REIT	3.4715 of 5 stars	$30.46 -2.5%	$37.17 +22.0%	-11.5%	$1.73B	$281.14M	205.17	N/A
IART Integra LifeSciences	1.4142 of 5 stars	$15.98 -0.3%	$14.00 -12.4%	+29.0%	$1.22B	$1.64B	N/A	4,427
ATEC Alphatec	3.8301 of 5 stars	$7.40 -4.5%	$18.58 +151.0%	-30.7%	$1.19B	$764.16M	N/A	700

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATRC) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AtriCure (ATRC) Competitors

ATRC vs. ITGR, SMA, IART, ATEC, and ANGO

How does AtriCure compare to Integer?

Summary

How does AtriCure compare to Smartstop Self Storage REIT?

Summary

How does AtriCure compare to Integra LifeSciences?

Summary

How does AtriCure compare to Alphatec?

Summary

How does AtriCure compare to AngioDynamics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATRC vs. The Competition

AtriCure Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AtriCure (ATRC) Competitors

ATRC vs. ITGR, SMA, IART, ATEC, and ANGO

How does AtriCure compare to Integer?

Does the media refer more to ITGR or ATRC?

Which has preferable earnings and valuation, ITGR or ATRC?

Do analysts prefer ITGR or ATRC?

Which has more risk and volatility, ITGR or ATRC?

Do insiders and institutionals hold more shares of ITGR or ATRC?

Is ITGR or ATRC more profitable?

Summary

How does AtriCure compare to Smartstop Self Storage REIT?

Do insiders & institutionals believe in ATRC or SMA?

Which has higher earnings & valuation, ATRC or SMA?

Does the media favor ATRC or SMA?

Which has more risk and volatility, ATRC or SMA?

Is ATRC or SMA more profitable?

Do analysts recommend ATRC or SMA?

Summary

How does AtriCure compare to Integra LifeSciences?

Which has better valuation and earnings, ATRC or IART?

Which has more volatility and risk, ATRC or IART?

Does the media prefer ATRC or IART?

Do institutionals & insiders hold more shares of ATRC or IART?

Do analysts prefer ATRC or IART?

Is ATRC or IART more profitable?

Summary

How does AtriCure compare to Alphatec?

Do insiders and institutionals hold more shares of ATRC or ATEC?

Does the media prefer ATRC or ATEC?

Which has preferable valuation and earnings, ATRC or ATEC?

Is ATRC or ATEC more profitable?

Which has more risk & volatility, ATRC or ATEC?

Do analysts recommend ATRC or ATEC?

Summary

How does AtriCure compare to AngioDynamics?

Does the media refer more to ATRC or ANGO?

Which has stronger earnings and valuation, ATRC or ANGO?

Which has more risk & volatility, ATRC or ANGO?

Do institutionals & insiders have more ownership in ATRC or ANGO?

Is ATRC or ANGO more profitable?

Do analysts recommend ATRC or ANGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATRC vs. The Competition

AtriCure Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools